Virbac SA
F:V16
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virbac SA
F:V16
|
FR |
|
A
|
Ardmore Shipping Corp
F:A61
|
BM |
|
E
|
Equinor ASA
SWB:DNQA
|
NO |
|
Cytokinetics Inc
NASDAQ:CYTK
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
XMUN:75C
|
CN |
|
Energy Solar Tech SA
F:DH4
|
ES |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
Multiconsult ASA
OSE:MULTI
|
NO |
|
JD.com Inc
F:013A
|
CN |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
E
|
Edel SE & Co KgaA
F:EDL
|
DE |
|
Avista Corp
NYSE:AVA
|
US |
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
Norbit ASA
OTC:NBITF
|
NO |
|
Transcat Inc
NASDAQ:TRNS
|
US |
|
Societe Generale SA
PAR:GLE
|
FR |
|
Landstar System Inc
NASDAQ:LSTR
|
US |
|
S
|
Sun Communities Inc
F:SCZ
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
XMUN:RL2
|
JP |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
2.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
390.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
361.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
202.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
257.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 253.4m EUR. This includes both short-term (13.6m EUR) and long-term (239.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.